← Open Payments lookup

ANDREW SEGRAVES: Open Payments

NPI 1487997110 · LEAWOOD, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$3,139 in 186 payments from 19 companies in 2025. Trend: 2023 $3,579 · 2024 $3,025 · 2025 $3,139

Food & beverage: $3,139
CompanyPaymentsAmount
Otsuka America Pharmaceutical, Inc.31$481
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)28$407
Vanda Pharmaceuticals Inc.14$345
ABBVIE INC.17$321
E.R. Squibb & Sons, L.L.C.22$254
Neurocrine BioSciences, Inc.14$223
Axsome Therapeutics, Inc.9$151
Lundbeck LLC7$146
Supernus Pharmaceuticals, Inc.8$138
Takeda Pharmaceuticals U.S.A., Inc.7$136

Products named: REXULTI, CAPLYTA, VRAYLAR, HETLIOZ, COBENFY, INGREZZA, Qelbree, TRINTELLIX.

Industry payments across KS — which companies pay providers there.